IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026)

IDEAYA Biosciences (IDYA) reported Amortizatization of Intangibles of $1.2 million for Q1 2026, down 67.95% on a YoY basis from $3.8 million in Q1 2025, and down 20.54% sequentially from $1.5 million in Q4 2025.

IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

IDEAYA Biosciences (IDYA) has 9 years of Amortizatization of Intangibles data on file, last reported at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 67.95% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (down 64.2% YoY), and the FY2025 full-year result was $10.0 million, down 57.06% from the prior year.
  • Amortizatization of Intangibles declined to $1.2 million in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $6.6 million in Q2 2024 to a low of -$349000.0 in Q1 2022.
  • A 5-year average of $2.7 million and a median of $2.6 million in 2023 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles jumped 4046.51% in 2023 and sank 69.0% in 2025, its largest moves.
  • Tracing IDYA's Amortizatization of Intangibles over 5 years: stood at $1.1 million in 2022, then surged by 243.92% to $3.9 million in 2023, then grew by 26.83% to $4.9 million in 2024, then tumbled by 69.0% to $1.5 million in 2025, then declined by 20.54% to $1.2 million in 2026.
  • Business Quant data shows IDYA's Amortizatization of Intangibles at $1.2 million in Q1 2026, $1.5 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 IDEAYA Biosciences 3.26 Bn 2.59 Bn - 1.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Mn
Mar 31, 2026 1.21 Mn
Dec 31, 2025 1.52 Mn
Dec 31, 2025 1.52 Mn
Sep 30, 2025 1.98 Mn
Sep 30, 2025 1.98 Mn
Jun 30, 2025 2.69 Mn
Jun 30, 2025 2.69 Mn
Mar 31, 2025 3.78 Mn
Mar 31, 2025 3.78 Mn
Dec 31, 2024 4.92 Mn
Dec 31, 2024 4.92 Mn
Sep 30, 2024 5.36 Mn
Sep 30, 2024 5.36 Mn
Jun 30, 2024 6.64 Mn
Jun 30, 2024 6.64 Mn
Mar 31, 2024 6.31 Mn
Mar 31, 2024 6.31 Mn
Dec 31, 2023 3.88 Mn
Dec 31, 2023 3.88 Mn